VVVladimira Vuletić

Vladimira Vuletić

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vladimira Vuletić has a total of 99 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Intracerebral Hemorrhage in Multiple Sclerosis: Disease Evolution or Treatment-Related Complication?: A Case Report

    by Isidora Semnic, David Bonifacic, Vladimira Vuletic

    Intracerebral hemorrhage (ICH) is an uncommon but clinically significant event in patients with multiple sclerosis (MS), and its relationship to disease-modifying therapies (DMTs) remains incompletely understood. We report the case of a patient with long-standing MS who developed an ICH. The patient had a 16-year history of MS and was reluctant towards long-term DMT. Cladribine was introduced as a high-efficacy treatment, and less than two years after treatment initiation, the patient experienced a spontaneous ICH. Despite the hemorrhagic event, cladribine therapy was continued, resulting in subsequent stabilization of MS disease activity, with only mild residual neurological deficit. A thorough evaluation revealed no alternative secondary causes neither conventional risk factors for the hemorrhage. Although current literature does not establish a definitive link between cladribine and ICH, the temporal relationship in this case enhances the possibility of a therapy-related contribution. Given the absence of definitive causal evidence, we propose that chronic neuroinflammation with impaired cerebrovascular autoregulation, compounded by therapy-induced immunosuppression, could contribute to the event. However, causality cannot be inferred from the single observation of disease versus treatment-related factors. Further data are needed to clarify hemorrhagic risk in MS patients receiving DMT and the need for continued pharmacovigilance when using high-efficacy immune-depleting therapies.

  • Open Access

    Microbial diversity in drug-naïve Parkinson’s disease patients

    by Eliša Papić, Valentino Rački, Mario Hero, Ana Nyasha Zimani, Mojca Čižek Sajko, Gloria Rožmarić, Nada Starčević Čizmarević, Saša Ostojić, Miljenko Kapović, Goran Hauser, et al.

    Parkinson’s disease (PD) is a neurological disorder characterized by rigidity, bradykinesia and tremor. Several genetic and environmental causes of PD are known, and there is emerging evidence of the possible contribution of the gut microbiome to the disease onset, severity, and response to therapy. While previous research has shown several differences in the microbiome of PD patients under therapy as opposed to healthy controls, few prospective studies have included drug-naïve patients. In order to evaluate the gut microbiome composition prior to therapy initiation, we collected and performed 16S rRNA gene sequencing of the stool samples from 49 drug-naïve PD patients and compared them to 34 diet and lifestyle-matched controls from the Croatian population (GiOPARK Project). While no significant alpha diversity difference was observed between the patients and controls, the differential relative abundance analysis showed an increase in Bacteroides fluxus, B. interstinalis, B. eggerthii, and Dielma fastidiosa in the drug-naïve PD patients compared to controls, while Alistipes, Barnesiella and Dialister spp. were decreased in patients compared to controls. Despite preserved overall diversity, these changes may indicate early microbial dysbiosis and represent a foundation for future studies exploring microbiome changes across disease progression and treatment.


  • Open Access

    The Role of Preoperative Immunonutritional Scores in Predicting Complications After Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease

    by Marina Raguž, Marko Tarle, Petar Marčinković, Hana Chudy, Darko Orešković, Vladimira Vuletić, Tonko Marinović, Darko Chudy

    Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder associated with systemic inflammation, immune dysregulation, and malnutrition, all of which may influence surgical outcomes. Subthalamic nucleus deep brain stimulation (STN DBS) is a widely used treatment for advanced PD, yet postoperative complications remain a concern. This study evaluates the predictive value of preoperative immunonutritional markers—including the Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) score, Aggregate Index of Systemic Inflammation (AISI), Lymphocyte-to-Monocyte Ratio (LMR), and systemic inflammatory response syndrome (SIRS)—for the risk of extracranial complications following STN DBS. Methods: A retrospective cohort study was conducted on 138 PD patients who underwent STN DBS. Clinical and laboratory data were analyzed to assess the association between preoperative immunonutritional markers and postoperative complications, including infections, wound healing disturbances, and surgical revisions. Logistic regression and receiver operating characteristic (ROC) analysis were performed to evaluate the predictive power of these markers. Results: SIRS emerged as the strongest predictor of complications (aOR = 6.99, 95% CI = 1.844–26.509), emphasizing the critical role of systemic inflammation in surgical outcomes. HALP, AISI, and LMR also demonstrated significant predictive potential, with HALP (AUC = 0.69) and LMR (AUC = 0.73) being the most robust predictors of complications. While albumin alone was not a significant predictor, it correlated with inflammatory markers and comorbidities, underscoring its role in broader risk assessments. Conclusions: This study underscores the value of preoperative immunonutritional markers in predicting complications following STN DBS in PD patients. Incorporating these markers into clinical risk stratification may enhance preoperative planning and personalized postoperative care, ultimately improving surgical outcomes. These findings, while promising, warrant validation through prospective, multicenter studies to refine predictive models and enhance patient outcomes.


  • Open Access

    Deep Brain Stimulation in Non-motor Symptoms of Neurodegenerative Diseases

    by Vladimira Vuletic, Valentino Racki, Darko Chudy, Nenad Bogdanovic

    Deep brain stimulation (DBS) is a functional neuromodulatory technique that involves the use of a neurostimulator to deliver electrical impulses to the brain. It primarily alleviates the motor symptoms in neurodegenerative diseases; however, it has been found beneficial in a multitude of neurological and psychiatric diseases, such as dystonia, essential tremor, Tourette syndrome, intractable pain, epilepsy, treatment-resistant depression, and obsessive-compulsive disorder. Nonmotor symptoms, such as neurobehavioral disorders, autonomic dysfunction, sleep dysfunction, and somatosensory dysfunction, play an important role in neurodegenerative diseases and have a significant impact on the quality of life. The effects of deep brain stimulation on these symptoms are not yet apparent, although early results are promising and warrant future investigations. The main problem in interpretation is the lack of studies in this field, as most have methodological issues or small sample sizes, which limit the strength of the evidence. However, it is clear that DBS has a promising future in the treatment of neurodegenerative diseases in general and will have a vital role in personalized medicine as functional neuroimaging and our understanding of brain physiology improve.


  • RANKL/RANK/OPG Axis Is Deregulated in the Cerebrospinal Fluid of Multiple Sclerosis Patients at Clinical Onset

    by Anton Glasnović, Maristela Stojić, Lidija Dežmalj, Ivana Tudorić-Đeno, Dominik Romić, Vjekoslav Jeleč, Anđelko Vrca, Vladimira Vuletić, Danka Grčević

    Objectives: Our study focused on the RANKL (receptor activator of nuclear factor-κB ligand)/RANK/OPG (osteoprotegerin) axis and selected proinflammatory/immunoregulatory upstream mediators in the peripheral blood (PBL) and cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients. Methods: PBL and CSF were collected from healthy controls (n = 35) and MS patients at the clinical onset of the disease (n = 33). In addition, PBL samples were obtained from relapse-remitting (RR)-MS patients (n = 30). Patients were assessed by means of the expanded disability status scale (EDSS) and routine laboratory parameters. Soluble (s)RANKL and OPG were measured in the CSF and plasma; gene expression was detected for RANKL, RANK, OPG, and selected cytokines/chemokines (interleukin [IL]-4, IL-10, IL-17, CCL2, and CXCL12) in PBL mononuclear cells. Results: The OPG level in the CSF was lower in MS patients at clinical onset than in controls. Moreover, the sRANKL/OPG ratio was higher in the CSF of MS patients at clinical onset and in the plasma of RR-MS patients than in controls. Gene expression of RANKL/RANK/OPG in PBL mononuclear cells was higher only in RR-MS patients. IL-4, CCL2, and CXCL12 were positively correlated and IL-10 was negatively correlated with RANKL/RANK expression. OPG was negatively correlated with EDSS and alkaline phosphatase level. Conclusion: Our study revealed that changes of RANKL/RANK/OPG axis are associated with MS, particularly the decreased OPG level in the CSF at disease onset. Therefore, these factors may serve as disease biomarkers and molecular targets of novel therapeutic approaches.


  • Diagnostic and therapeutic approach to a patient with cognitive impairment

    by Matija Sošić, Vladimira Vuletić, Zoran Tomić, Nenad Bogdanović

    Dementia is a clinical syndrome which manifests in a decline in one or more cognitive domains (learning, memory, language, egsecutive function, attention, perceptive, motor and social cognition) that affects patients rutine daily...


  • Calcium–axonemal microtubuli interactions underlie mechanism(s) of primary cilia morphological changes

    by Vlado A. Buljan, Manuel B. Graeber, R. M. Damian Holsinger, Daniel Brown, Brett D. Hambly, Edward J. Delikatny, Vladimira R. Vuletic, Xavier N. Krebs, Ilijan B. Tomas, John J. Bohorquez-Florez, et al.

    We have used cell culture of astrocytes aligned within microchannels to investigate calcium effects on primary cilia morphology. In the absence of calcium and in the presence of flow of media (10 μL.s−1) the majority (90%) of primary cilia showed reversible bending with an average curvature of 2.1 ± 0.9 × 10−4 nm−1. When 1.0 mM calcium was present, 90% of cilia underwent bending. Forty percent of these cilia demonstrated strong irreversible bending, resulting in a final average curvature of 3.9 ± 1 × 10−4 nm−1, while 50% of cilia underwent bending similar to that observed during calcium-free flow. The average length of cilia was shifted toward shorter values (3.67 ± 0.34 μm) when exposed to excess calcium (1.0 mM), compared to media devoid of calcium (3.96 ± 0.26 μm). The number of primary cilia that became curved after calcium application was reduced when the cell culture was pre-incubated with 15 μM of the microtubule stabilizer, taxol, for 60 min prior to calcium application. Calcium caused single microtubules to curve at a concentration ≈1.0 mM in vitro, but at higher concentration (≈1.5 mM) multiple microtubule curving occurred. Additionally, calcium causes microtubule-associated protein-2 conformational changes and its dislocation from the microtubule wall at the location of microtubule curvature. A very small amount of calcium, that is 1.45 × 1011 times lower than the maximal capacity of TRPPs calcium channels, may cause gross morphological changes (curving) of primary cilia, while global cytosol calcium levels are expected to remain unchanged. These findings reflect the non-linear manner in which primary cilia may respond to calcium signaling, which in turn may influence the course of development of ciliopathies and cancer.


  • Excellent outcome of pallidal deep brain stimulation in DYT6 dystonia: A case report

    by Vladimira Vuletic, Darko Chudy, Fadi Almahariq, Valerija Dobricic, Vladimir Kostic, Nenad Bogdanovic